Melasma Pharmaceuticals is rated 3 out of 5 in the category #lifescience #melasma #pharmaceuticals #pharma #novelmolecule. Read and write reviews about Melasma Pharmaceuticals. Melasma Pharmaceuticals is spin off company of Micar Innovation, registered in Sofia, Bulgaria. Under terms of the agreement, Micar Innovation grants Melasma Pharmaceuticals (Sofia - Bulgaria) an exclusive option to license and develop MIC8411 drugs targeting Melasma disease. Melasma Pharmaceuticals capital is in the hands of Micar Innovation driven by impact and provide value to our future investors.
Address
38A, Karamfil street
Company size
1-10 employees